In a systematic review and meta-analysis of 38 randomized controlled trials comprising 149,051 participants, omega-3 fatty acids — such as eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids — were associated with reducing cardiovascular mortality and other cardiovascular outcomes; the cardiovascular risk reduction was more prominent with EPA monotherapy than with EPA+DHA. Khan et al. performed a meta-analysis of 38 randomized controlled...